Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Metabolism01:19

Regulation of Metabolism

12.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.4K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

6.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.8K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

4.4K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.2K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.2K
Regulation of Food Intake01:30

Regulation of Food Intake

3.2K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

958
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
958

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Astrocytic mGluR5 Regulation of Synaptic Transmission is Activity-Dependent in Adult Rats.

Glia·2026
Same author

Harnessing a snake metabolite to control food intake.

Trends in endocrinology and metabolism: TEM·2026
Same author

Cannabidiol prevents mucosal HIV-1 transmission by targeting Langerhans cells, dendritic cells, macrophages and T-cells.

Mucosal immunology·2026
Same author

SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.

Diabetes, obesity & metabolism·2026
Same author

Impact of eating behaviour on craniopharyngioma-associated obesity.

Journal of pediatric endocrinology & metabolism : JPEM·2026
Same author

GHSR agonism increases blood glucose but delays food intake in GHSR hyperresponsive rats.

Journal of neuroendocrinology·2026

Related Experiment Video

Updated: Apr 3, 2026

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.8K

Endocannabinoids and Metabolic Disorders.

Blandine Gatta-Cherifi1,2,3, Daniela Cota4,5

  • 1INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U862, 33000, Bordeaux, France. blandine.gatta-cherifi@chu-bordeaux.fr.

Handbook of Experimental Pharmacology
|September 27, 2015
PubMed
Summary
This summary is machine-generated.

The endocannabinoid system (ECS) regulates calorie intake and metabolism, offering therapeutic potential for obesity and eating disorders. Recent research advances may enable more targeted ECS therapies, overcoming previous limitations.

Keywords:
CB1 receptorCB2 receptorEating disorderEndocannabinoidMetabolic disorderObesity

More Related Videos

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

696
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

773

Related Experiment Videos

Last Updated: Apr 3, 2026

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.8K
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

696
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

773

Area of Science:

  • Neuroscience
  • Metabolic Research
  • Pharmacology

Background:

  • The endocannabinoid system (ECS) plays a crucial role in regulating calorie intake, metabolism, and storage.
  • Dysregulation of the ECS is implicated in obesity, diabetes, and eating disorders.
  • Previous CB(1) receptor blockers faced limitations due to psychiatric side effects.

Purpose of the Study:

  • To review recent advances in understanding the ECS's role in eating behavior and energy balance.
  • To explore novel strategies for selectively targeting the ECS for therapeutic development.
  • To discuss the potential of the ECS as a pharmacotherapeutic target for metabolic and eating disorders.

Main Methods:

  • Review of recent animal and human research on the ECS.
  • Analysis of mechanisms underlying eating behavior and energy balance regulation by the ECS.
  • Evaluation of potential therapeutic targets within the ECS.

Main Results:

  • New insights into the ECS mechanisms regulating appetite and metabolism.
  • Identification of pathways for more specific and selective ECS modulation.
  • Evidence supporting the ECS as a viable target for metabolic diseases.

Conclusions:

  • Recent discoveries offer promising avenues for developing new therapies for obesity, metabolic syndrome, and eating disorders.
  • Targeting the ECS with greater specificity may overcome the side effects associated with earlier treatments.
  • Further research into ECS pathways could lead to breakthrough treatments for metabolic and eating disorders.